Moving on to greener pastures.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For the record I got seduced into TransEnterix because of the money I have made on Intuitive and Mazor.
Same Reason I bought Titan in 2014 and sold in 2015.
Not a lurker but a former investor from 2014-2015. Lost some money on 15,000 shares. but not looking back. I was curious as I am in Mazor and Intuitive and doing great with both of them. Also have a position in TransEnterix which I think is very speculative unless they make a deal like Mazor did with Medtronic.
Mazor languished for years like Titan if you go back to the 2010 - 2015 time frame. They now have made it big time. Companies like Titan and TransEnterix struggle as the process to get approval is time consuming and burns all the capital.
To survive this company needs a partner like Mazor got with Medtronic.
https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other
Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.
Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.
This partnership is a win-win for both companies.
They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.
TransEnterix needs validation by having a sales and marketing partner. With out it the company is another Titan
To survive this company needs a partner like Mazor got with Medtronics.
https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other
Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.
Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.
This partnership is a win-win for both companies.
They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.
TransEnterix needs validation by having a sales and marketing partner. With out it the company is another Titan
What are bones worth if another company bought them out for nothing or after bankruptcy?
who might be the logical player to pick they bones for nothing?
Correct on buyer situation. But the need a sales and marketing partner. Can’t go it alone they don’t have the capital or time to build a sales team. Beyer to partner like Mazor did.
Below is an article from a website today talking about the benefits of the partnership between MDT & Mazor Robotics.
Read the article about Mazor.
Great article on why this company has a lot of room to run with $MDT as a partner.
https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other
Excerpt:
The $72 million invested by Medtronic (as of Sept 2017) has allowed Mazor to scale at a much faster rate then they ever would have without the capital.
Excerpt:
Medtronic also has warrants allowing them to buy another 1.2 million shares, which could bring their total investment to $125 million, or 14% ownership of the company.
Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.
Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.
This partnership is a win-win for both companies.
They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.
What this company needs in order to have their stock grow is a strong partner Like Mazor Robotics has with Medtronic.
Below is an article from a website today talking about the benefits of that partnership.
TransEnterix does not have the capital to go it alone. Hopefully they will find a partner or will be purchased because of their advanced technology by a company like intuitive surgical.
Read the article about Mazor.
Great article on why this company has a lot of room to run with $MDT as a partner.
https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other
Excerpt:
The $72 million invested by Medtronic (as of Sept 2017) has allowed Mazor to scale at a much faster rate then they ever would have without the capital.
Excerpt:
Medtronic also has warrants allowing them to buy another 1.2 million shares, which could bring their total investment to $125 million, or 14% ownership of the company.
Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.
Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.
This partnership is a win-win for both companies.
They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.
Great article on why this company has a lot of room to run with $MDT as a partner.
https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other
Excerpt:
The $72 million invested by Medtronic (as of Sept 2017) has allowed Mazor to scale at a much faster rate then they ever would have without the capital.
Excerpt:
Medtronic also has warrants allowing them to buy another 1.2 million shares, which could bring their total investment to $125 million, or 14% ownership of the company.
Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.
Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.
This partnership is a win-win for both companies.
They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.
It actually appears that he was working on all this restructuring since he left his position. Job well done by ‘Matt.
That is why you see Matt being compensated for his hard effort.
Great job on restructuring by ‘Matt.
The long-term debt restructure till 2021 at 5.75%. That is not the rate a company that is going bank rep gets.
It looks like trading was halted after hours tomorrow should be very interesting.
I don’t see this hitting $3.00 again for a year unless the have some sales
Time to bail from this investment. Not sure it’s going to grow
Sometimes when it gets really windy you can’t hear the rumbling of the market. Perhaps the whistle of the train has been ignored. Time will tell us if the Rumbling is the train moving forward with MannKind moving forward as their sales and. PPS move upward.
Yep! I agree with you Martin.
I ignore background noise as the Trend is only negative if you pay attention the noise .
Otherwise the Trend has turned positive for MannKind.
The most Positive trend began with the Sale of the 61 million in treasury shares.
So how do you think they got people to buy $61 million worth of stock @ six dollars? Don’t you think that these educated investors knew what they were buying? Do you think that the chairman of the board would’ve bought $1 million worth of shares himself if he thought he was pissing it down the drain.
Did he buy those years so that he could have a write off on some other capital gain he made in the market?
We don’t know who bought the other $60 million in shares. What we do know is that they were treasury shares so that was beneficial to the company.
The buyer of the treasury shares didn’t buy them to lose money.
Stay tuned!
Actually if you go back and listen to the 2010 presentation that Al Mann gave John Hopkins University he predicted the insulin pump would become obsolete.
Yes he said in 2010 that it’s a pump would eventually go away because of Afrezza.
This is a long presentation over one hour in length. Listen at the 26:50 mark.
Al Mann at John Hopkins 2010:
Well, Al predicted this would happen at the 26:50m.
Then again he outlined the label which was just approved at 36m.
Interesting story about J & J quitting the pump business. It leaves MDT and a couple of weak companies behind in the business. This hopefully is going to be a positive for MannKind as some patients have ditched the pump.
Worth reading this story published today. Makes mention of Al Mann and selling his pump business to MDT. Al Mann Knew the value of the Pump business in 2001 and I believe that MannKind management and the board know the value of MannKind in 2017
http://www.latimes.com/business/lazarus/la-fi-lazarus-diabetes-animas-20171017-story.html
Patients face tough choices when a healthcare provider calls it quits
"In my case, J&J said its “partner of choice” is Medtronic, which means it’s steering its 90,000 customers to the industry leader.
Medtronic, the world's largest stand-alone medical device maker, acquired its Northridge-based MiniMed pump business in 2001 from Los Angeles entrepreneur Alfred Mann for nearly $3.3 billion."
I would bet it closes today about $3.50 The HFT control the game and they ran it up for retail investors to buy and they will driver it down by the close.
perhaps worth that after they get 12 to 24 months of US sales. This is still a company that has potential but no sales yet. Fair price is about $3.50 and I bet we end the day there after 100,000,000 shares trade today.
HFT is grinding the profits today.
Only listened to the call and then impulsively bought the shares. Should have gone 2X what I purchased. Oh well. nice investment for 7:30 AM central time. Glad I got in when I did.
Now sure what is going here. In at $1.37 and enjoyed the ride up to 2.10 but now it seems to be in troubled waters. What is the problem?
I was lucky to get in to TRXC today. They got FDA approval on 20 procedures last week. But they don't have any US sales yet. Is this pulling down CVRS?
Wow! got in Pre-market today for 2,500 shares and I was worried about it pulling back. I have other Robotic companies Like intuitive ISRG and Mazor Robotics. I had been watching this stock for about 2 weeks and noticed they got fDA approval last Friday.
Glad I listened to the call this AM and then immediately purchased. This should be a long term holder.
I have been in ISRG since 2010 and smile every day with the money made there holding a great equity. Hopefully TRXC will be in that same class 10 years from now.
Mazor on the Move with new hire.
Great read on Israeli company Mazor Robotics.
https://finance.yahoo.com/news/mazor-robotics-appoints-medical-device-083000027.html
Currently there operating systems is based on spinal surgery but they are going to expand into other areas.
He will lead the implementation of our strategies to develop Mazor’s business beyond our current spine focus as we pursue our goal of being the leader in image based medical robotics,” commented Mr. Hadomi.
You didn't read my posting very carefully.
I said this :
"Then again why partner if you have a better technology like Technosphere."
Maybe they can partner with this company who seems to have a big bong device. Then again why partner if you have a better technology like Technosphere.
As we have learned treprostinil is a drug that would work well in Technosphere.
https://www.tyvaso.com/dtc
Tyvaso inhalation solution. Tyvaso inhalation solution is used for: Treating pulmonary arterial hypertension (PAH) (high blood pressure in the arteries of the lungs) in certain patients to increase walk distance. It may also be used for other conditions as determined by your doctor.
Or this for dosing treprostinil
I believe that most patients would want to use an easy to carry inhaler.
Fidelity lending Program now paying 63% to lenders and as of Friday the shorts were paying 99% to borrow the shares. Seems like the perfect storm on one side of the deal or the other.
Lending Side:
Borrowing side
Yesterday was Friday the 13th
Monday should be a very interesting day. Perhaps even Sunday on the TASE? Perhaps the PPS will rise in anticipation of any news on Monday Pre-Market as to who purchased the 60 Million in MannKind Stock at $6.00
TASE opens at 3:45 AM Sunday morning.
https://www.tase.co.il/Eng/General/Company/Pages/companyMainData.aspx?subDataType=0&companyID=001652
Very few of us stupid retail investors get what is happening with MannKind. We are just in it for the Ride in either direction. We know the Product Afrezza is a good one and that eventually it will be the Gold standard for T1D & T2D treatment. So right now its a ticking time bomb....
As the Clock churns the SHORT or LONG has to decide how to play the MannKind game.
You are spreading FUD.
Rite aid is not going to be delisted . The stock has to go below one dollar for several months. Before that would ever happened. They then have a 12month cure Period.
At that point if the stock price was not up they could do a reverse split.
So don’t spread FUD.
If Amazon wants the package it’s not a problem they will work it out in 12 to 18 months. It vaporizes.
That’s just another write off for Amazon
I have a feeling why the PPSdidn’t move it will be a share exchange only
You think that Kresa didn't buy it because he is bullish? He is the chairman and could have purchased at the open market but he wanted to create permanence of equity that would stay and help the company. He bought above the market and the other shares that have been marketed by http://www.hcwainwright.com/transactions
were sold.
So I don't know what you mean as being a problem with legality? I personally don't see this a pump by any party as somebody purchased the shares. $61,000,000 worth of shares.
They had the treasury stock to issue to bring equity into the company. My view is job well done by Management / Board of directors. This was the job of Chairman Kresa more than it was Mike. Kresa has this background from his days at GM and Northrup Gruman
Glad to see he was confident enough put his money into a winner.
Tombstone from Wainwright which is the parent company of Rodman & Renshaw
MannKind is not looking to sell the company but to build it. Perhaps the other 60 million will be unveiled by Pre-market Monday trading. Could be a very exciting week for MannKind shareholders.
Kaboom!
Thank you Chairman KENT KRESA for making this bullish statement.
Impressive resume:
http://investors.mannkindcorp.com/secfiling.cfm?filingid=1209191-17-56898&CIK=899460
Now lets see what drips out on the other shares? Will there be another filing tonight? or Premarket Monday?
Only management knows.
What are the lenders getting paid for the borrowed shares?
I can see it on MNKD as Fidelity is paying 59% to lenders and 99% to borrowers. But I can't see it on Rite Aid. Anybody know the lending rate?
Best not to be sitting on the sidelines on a Pre-Market Monday morning.
Who knows what might happen.
Walgreens deal ahead? Amazon potential deal (not likely)buy you never know until its too late.
Could Amazon just make an offer and buy the PBM side Envisions?
Walk away with no debt on the remaining stores that Walgreens does not buy and the cash from the sale of Envision would make a company with no debt?
That is a rights option for Kermit extending out to 2027
You can find the MannKind Proboards Scripts link page here.
http://mnkd.proboards.com/board/19/afrezza-script-counts-metrics
Martin the best information you can get at MNKD Proboards http://mnkd.proboards.com/
where Trend evidently got his script numbers from this AM. My best guess on the HC Wainwright deal is a big investor or equity partner. I don't believe that has to surface for 45 days but I might be wrong.
Label change will take at least 6 months before seeing impact on increasing scripts.
Oh a retail customer can short one retail brokerage is charging 99% today to short. Last week it got as high as 113%.
They pay lenders of shares today 55%. So many long investors have been in the lending program for several years. The return is much better at $5.00 per share than it was at .75 per shares.
Just do the math on the transaction.
Hypothetical:
50,000 shares x $5.00 per share = $250,000 divided by
360 days = $694.44 per day x 31 days a month = $21,529.77 per month.
So a person in the brokers lending program can buy more shares with their monthly interest payment.
Rich you are correct. Was it one entity or several? If it was only one entity that is very bullish as they are confident that MannKind will be TRENDING upwards. Perhaps even a company making a buy in to the company.
These are treasury shares that were sold so all funds other than then the fees going to the Wainwright go to MannKind. The company has enough treasury shares left to do a 2nd offering at some point in the future. You can bet that MannKind will not make this available for a long time as you want to save them for when the stock might be at a much higher PPS perhaps at $15. Or $20.
Mike Castagna played this perfectly and timed the offering and price when news was TRENDING up. The reason we watch the PPS go from $1.25 to over $6.50 earlier this week is that the news of the offering hit the street in some kind of rumor fashion. Look at the day last week 70 Million shares of 100 million traded. Everybody wanted in to MannKind.
My GUEST is there is more to come before the end of 2017. I can only hope as I have believed that eventually this company would become a winner.
Al Mann didn't spend 2 Billion of his own cash to have a failure. The road traveled has been tough. Most companies like this get destroyed as it take 10 + years to get FDA approval. It did take that type of effort for MannKind. The injected insulin cartel does not want MannKind to survive. They have tried every trick to kill the company. Going back to the 2010 Christmas Day massacre by Martin Shrekli with letters to the FDA commissioners who worked for Margret Hamburg. Hamburg's husband owned a Hedge fund that Martin was once affiliated too. That massacre cost Mannkind several billion more. Every step has had problems. But the one thing that nobody counted on is that AFREZZA is just too good of a product and eventually will change the INSULIN Market.
Hang on the best is yet to come.
Martin it was a private offering of shares by HC Wainwright. The deal has closed as evidenced by their transaction page of their web site. They have a tombstone showing its done.
http://www.hcwainwright.com/transactions
Now the question is purchased the negotiated shares. Was it a single entity? If so that is very bullish or was it several different entities. One think you can take away from this is that somebody thought that MannKind shares were worth $6.00 a share since they willingly made the purchase.
Who was it? Somebody buying into the company? If this is the case then we will perhaps learn who it was within 45 days as they would have more than 5% ownership.
This transaction was from MannKind treasury shares and did not have to be sold on the open market. This type of transaction helps inject cash into the company. Where shares already on the market don't help the company as they are shorted and traded downward. My guess is that whoever purchased the shares has decided that MannKind is worthy of the investment.
As you watched trading today you saw that for the most part trading was very stable. Shorts tried to drive down the PPS but it held pretty well.
If this offering was horrible for MannKind you would have seen the PPS drop like a rock.
Search out other explanations on the deal at MNKD Proboards as it was discussed there extensively and on stocktwits. There is a writer named Nate Pile who has followed MannKind for many years and you can do a browser search for his name and find some good threads.
Is MannKind out of the woods? Not yet but its TRENDING in the right direction.
Mike Castagna CEO is a remarkable man who is working tirelessly to make MannKind a winner.
You will find the Wainwright Tombstone at this link.
http://www.hcwainwright.com/transactions